First, we selected a panel of six SCLC cell lines to determine BGA002 in vitro activity: five cell lines were MYCN amplified (MNA) and one was characterized by MYCN overexpression, but not amplification (not-MNA). Here, MYCN is linked to small cell lung carcinoma.